Cardiff Oncology

CRDFNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$58.945 M

$0.76 -12.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Cardiff Oncology (CRDF) has a market capitalization of $58.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$593.0K

#3500 by revenue

Earnings

-$45.9K

Loss-making

Shares outstanding

77,795,249

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#119Champions OncologyCSBR$66.7M
#120Cognition TherapeuticsCGTX$60.2M
#121Cardiff OncologyCRDF$58.9M
#122Kalaris TherapeuticsKLRS$55.9M
#123Eloxx PharmaceuticalsELOX$52.1M

What if Cardiff Oncology were worth as much as…

Open the what-if tool →

Gold $28.2T

$362,963.99

Per share 479,034× higher

Bitcoin $1.53T

$19,639.35

Per share 25,920× higher

Apple $5.02T

$64,474.15

Per share 85,092× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Cardiff Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.